345 related articles for article (PubMed ID: 19795182)
1. New drugs for migraine.
Stovner LJ; Tronvik E; Hagen K
J Headache Pain; 2009 Dec; 10(6):395-406. PubMed ID: 19795182
[TBL] [Abstract][Full Text] [Related]
2. Is there an inherent limit to acute migraine treatment efficacy?
Bigal ME; Ho TW
J Headache Pain; 2009 Dec; 10(6):393-4. PubMed ID: 19820895
[No Abstract] [Full Text] [Related]
3. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
Tfelt-Hansen PC
J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
[TBL] [Abstract][Full Text] [Related]
4. Emerging targets in migraine.
Hoffmann J; Goadsby PJ
CNS Drugs; 2014 Jan; 28(1):11-7. PubMed ID: 24318669
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.
Paone DV; Staas DD
Expert Opin Ther Pat; 2009 Dec; 19(12):1675-713. PubMed ID: 19939188
[TBL] [Abstract][Full Text] [Related]
7. CGRP-receptor antagonism in migraine treatment.
Edvinsson L
Lancet; 2008 Dec; 372(9656):2089-90. PubMed ID: 19036426
[No Abstract] [Full Text] [Related]
8. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
Edvinsson L; Linde M
Lancet; 2010 Aug; 376(9741):645-55. PubMed ID: 20416945
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Cui XP; Ye JX; Lin H; Mu JS; Lin M
Pain Pract; 2015 Feb; 15(2):124-31. PubMed ID: 24382126
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
11. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide receptor antagonists for the treatment of migraine.
Williams TM; Burgey CS; Salvatore CA
Prog Med Chem; 2009; 47():1-35. PubMed ID: 19328288
[No Abstract] [Full Text] [Related]
13. CGRP antagonists: hope for a new era in acute migraine treatment.
Schelstraete C; Paemeleire K
Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
[TBL] [Abstract][Full Text] [Related]
14. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
Tepper SJ; Cleves C
Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
[TBL] [Abstract][Full Text] [Related]
15. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
Villalón CM; Olesen J
Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update.
Tfelt-Hansen P
Curr Clin Pharmacol; 2012 Feb; 7(1):66-72. PubMed ID: 22299771
[TBL] [Abstract][Full Text] [Related]
17. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
Tepper SJ; Stillman MJ
Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptor antagonists: an expanding drug class for acute migraine?
Negro A; Lionetto L; Simmaco M; Martelletti P
Expert Opin Investig Drugs; 2012 Jun; 21(6):807-18. PubMed ID: 22512641
[TBL] [Abstract][Full Text] [Related]
19. Novel Medications for the Treatment of Migraine.
Ceriani CEJ; Wilhour DA; Silberstein SD
Headache; 2019 Oct; 59(9):1597-1608. PubMed ID: 31559638
[TBL] [Abstract][Full Text] [Related]
20. Migraine: Telcagepant provides new hope for people with migraine.
Edvinsson L
Nat Rev Neurol; 2009 May; 5(5):240-2. PubMed ID: 19488079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
